COA/RT-2026-155Verified
Save as PDFCertificate of Analysis
PuriLab Analytical
Retatrutide 20 mg
RT-2026-155Lot RT20-2611001-1Analyzed November 20, 2026

Timeline
Ordered
November 18, 2026
Received
November 20, 2026
Analyzed
November 20, 2026
Sample
Name
Retatrutide 20 mg
Expected
Retatrutide
Amount
1 vial, lyophilized powder
Testing
Client
P-LabTest
Test type
Content & purity, fentanyl
Method
HPLC-UV
Group test
Vials tested
1 vial, shared result
Contributors
7 people
Shared by
Joe Glez, Raul Flores, Carlos Delgado, Laura Reveles, Joe Glez 2 (Saudi Vel Spot), Raul Flores (yari), Joe Glez 3
Content, how much is in it
19.00mg
Label claim: 20 mg
Purity, how clean it is
99.5%
Measured, not estimated. Purity is calculated from the full chromatogram shown above.
Fentanyl
NOT DETECTED
Screening cutoff 20 ng/mL
Chromatogram
HPLC-UV
13.40 min, Retatrutide, 99.5%
Analyst Comments
White lyophilized powder, blue flip-cap vial, received sealed.
Analyst Signature
Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 20, 2026
Verification Code
RT-7TA7-VIFO
Verify at purilab.org/verify/RT-7TA7-VIFO
Scan to Verify
RT-7TA7-VIFO
Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.
PuriLab Analytical|admin@purilab.org
Page 1 of 1